Dianabol and MK-2866 Interaction

Avoid
Mechanism-based 64% confidence

Dianabol and MK-2866 have a potentially harmful interaction with 64% confidence. Both Dianabol and MK-2866 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Both compounds affect the gonads and liver and heart, so monitoring these systems is recommended.

Compound Profiles

Dianabol

Oral Anabolic Steroid | Classic Mass Builder

Dianabol exerts its effects primarily through binding to the androgen receptor (AR), promoting nitrogen retention, protein synthesis, and glycogenolysis in skeletal muscle tissue. Its 17-alpha-alkylated structure allows it to survive first-pass hepatic metabolism, enabling oral bioavailability but placing significant stress on the liver.

Half-life: ~4-6 hours Typical dose: 20-50 mg/day anabolic
androgen receptoraromatase androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

MK-2866

Selective Androgen Receptor Modulator | Muscle Wasting Research

MK-2866 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a partial agonist in muscle and bone tissue. Upon binding, the MK-2866-AR complex undergoes a conformational change that promotes nuclear translocation and interaction with androgen response elements (AREs) on DNA, activating transcription of genes involved in protein synthesis, nitrogen retention, and myogenic differentiation.

Half-life: ~24 hours Typical dose: 10-25 mg/day oral sarm, anabolic
androgen receptormtormyostatin androgeniccarcinogenic riskhepatotoxichpta suppressive
View full profile

Combined Organ Load

Gonads
elevated
Liver
elevated
Heart
moderate

Shared Safety Flags

2x 2 androgenic compounds (Dianabol, MK-2866). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the carcinogenic-risk safety flag (Dianabol, MK-2866). Monitor accordingly.
2x 2 hepatotoxic compounds (Dianabol, MK-2866). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Dianabol, MK-2866). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Dianabol, MK-2866). Get lipid panel mid-cycle — consider adding lipid support.

Frequently Asked Questions

Can I take Dianabol with MK-2866?

Combining Dianabol with MK-2866 is not recommended. Both Dianabol and MK-2866 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Dianabol and MK-2866 safe together?

This combination carries significant risk. Both Dianabol and MK-2866 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Dianabol and MK-2866?

Both Dianabol and MK-2866 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Dianabol and MK-2866?

Dianabol has a half-life of ~4-6 hours and MK-2866 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Dianabol vs MK-2866

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.